Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: A randomized controlled trial

Climacteric

Volumn 12, Issue 5, 2009, Pages 419-426

  Haines, C ^a   Yu, S L ^b   Hiemeyer, F ^c   Schaefers, M ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c BAYER PHARMA AG   (Germany)

Author keywords

Asian; Estradiol; Menopausal; Micro dose; Postmenopausal; Transdermal; Vasomotor

Indexed keywords

ESTRADIOL; PLACEBO;

ADULT; AGED; ARTICLE; ASIAN; BREAST DISEASE; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GYNECOLOGIC DISEASE; HOT FLUSH; HUMAN; INCIDENCE; INFECTION; INFLUENZA; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MULTICENTER STUDY; PH MEASUREMENT; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; UTERINE CERVIX DYSPLASIA; VAGINA BLEEDING; VASOMOTOR REFLEX; WELLBEING;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HONG KONG; HOT FLASHES; HUMANS; HYDROGEN-ION CONCENTRATION; MALAYSIA; MIDDLE AGED; PHILIPPINES; PLACEBOS; SINGAPORE; THAILAND; TIME FACTORS; VAGINA;

EID: 70350645474     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902748967     Document Type: Article

References (17)

1. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now? Lancet 2005;366:409-421
2. Bachmann GA. Menopausal vasomotor symptoms: a review of causes, effects and evidencebased treatment options. J Reprod Med 2005; 50:155-165
3. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180: S312-16
4. Rolnick SJ, Jackson J, Kopher R, Defor TA. Provider management of menopause after the findings of the Women's Health Initiative. Menopause 2007;14:441-449
5. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/ progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004 Oct 18:CD002978
6. National Institutes of Health State-of-the- Science Conference Statement: Management of Menopause-Related Symptoms. Ann Intern Med 2005;142:1003-1013
7. Skouby SO, Al-Azzawi F, Barlow D, et al. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas 2005; 51:8-14
8. Pines A, Sturdee DW, Birkhä user MH, et al. On behalf of the Board of the International Menopause Society. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181-194 (Pubitemid 46752441)
9. Tan D, Darmasetiawan S, Haines CJ, et al. Guidelines for hormone replacement therapy of Asian women during the menopausal transition and thereafter. Climacteric 2006;9: 146-151
10. North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-182
11. Ettinger B, Ensrud KE, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004;104:443-451
12. Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol 2005;105:779-787
13. Bachmann GA, Schaefers M, Uddin A, Utian WH. Lowest effective transdermal 17b-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2007;110:771-779
14. Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-276
15. Meisels A. The maturation value. Acta Cytol 1967;11:249
16. Tan D, Haines CJ, Limpaphayom KK, Holinka CF, Ausmanas MK. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study. Maturitas 2005;52:35-51
17. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-1079